Drug Shortage Report for BUPIVACAINE INJECTION BP
| Report ID | 51428 |
| Drug Identification Number | 02443686 |
| Brand name | BUPIVACAINE INJECTION BP |
| Common or Proper name | BUPIVACAINE INJECTION BP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | BLOCK/INFILTRATION EPIDURAL |
| Packaging size | 10 VIALS |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-06-01 |
| Estimated end date | 2018-06-22 |
| Actual end date | 2018-08-08 |
| Shortage status | Resolved |
| Updated date | 2018-08-09 |
| Company comments | Product is on 100% allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-08-09 | English | Compare |
| v4 | 2018-08-08 | French | Compare |
| v3 | 2018-08-08 | English | Compare |
| v2 | 2018-06-05 | French | Compare |
| v1 | 2018-06-05 | English | Compare |
Showing 1 to 5 of 5